Clinical Trials Browser

Phase 2 × Ureteral Neoplasms × 130-nm albumin-bound paclitaxel × Clear all

NCT07125547 2025-08-15

Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer

Phase 2 Recruiting

Ureteral Neoplasms